Skip to main content
Karen Melendez, MD, Psychiatry, Statesville, NC

KarenLMelendezMD

Psychiatry Statesville, NC

Physician

Are you Dr. Melendez?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 41 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1703 Davie Ave
    Statesville, NC 28677
    Phone+1 704-819-9191
    Fax+1 704-872-3782

Summary

  • Dr. Karen Melendez, MD is a board certified psychiatrist in Statesville, North Carolina. She is currently licensed to practice medicine in North Carolina, South Carolina, and California. She is affiliated with Haywood Regional Medical Center.

Education & Training

  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Child and Adolescent Psychiatry, 2006 - 2008
  • Temple University Hospital
    Temple University HospitalResidency, Psychiatry, 2003 - 2006
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - Present
  • NC State Medical License
    NC State Medical License 2008 - 2025
  • SC State Medical License
    SC State Medical License 2008 - 2011
  • PA State Medical License
    PA State Medical License 2003 - 2006
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Press Mentions

  • Despite Dwindling Demand for COVID-19 Vaccines, Bay Area Counties Plan to ‘Double Down’ on New Strategy
    Despite Dwindling Demand for COVID-19 Vaccines, Bay Area Counties Plan to ‘Double Down’ on New StrategyMay 4th, 2021